VEGFA and neoplasm: Furthermore, these data support the pedagogy that a single agent, such as anti-VEGF therapy, responding to the high-VEGF found in patient serum 52 may not be as effective as a dynamic therapeutic approach that responds to the progressing tumor microenvironment.